Research news

Thursday, September 3, 2020 Short pulses of focused ultrasound can help release cancer drugs on target

Breakthrough pre-clinical study published in Science Advances

Monday, August 31, 2020 Meet our new Platform Director of Physical Sciences

Dr. Bojana Stefanovic is a renowned scientist and a global leader in developing new methods for imaging brain function

Tuesday, August 25, 2020 Study: New 'echo-focusing' approach for focused ultrasound is feasible, safe, and more efficient

New approach may enable more patients with essential tremor to benefit from cutting-edge therapy

Tuesday, August 25, 2020 $1.1 million grant to support Sunnybrook world-first study investigating early-stage interventions for cognitive decline

Congratulations to Dr. Krista Lanctôt, senior scientist and recipient of the Alzheimer's Association's 2020 Part the Cloud-Gates Partnership Grant Program

Wednesday, July 29, 2020 A common diabetes medication may slow memory decline in Alzheimer's disease

Researchers at Sunnybrook Research Institute and the University of Toronto found that the rate of memory decline was slower in people with Alzheimer’s disease taking a specific class of anti-diabetic drug, known as a dipeptidyl peptidase-4 (DPP4) inhibitor.

< 42 43 44 45 46 47 48 >